BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23580087)

  • 1. Mechanism of Roux-en-Y gastric bypass treatment for type 2 diabetes in rats.
    Yu H; Zheng X; Zhang Z
    J Gastrointest Surg; 2013 Jun; 17(6):1073-83. PubMed ID: 23580087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
    Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
    Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
    Zhang S; Guo W; Wu J; Gong L; Li Q; Xiao X; Zhang J; Wang Z
    Med Sci Monit; 2017 May; 23():2151-2158. PubMed ID: 28477035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y; Zhou Y; Wang Y; Geng D; Liu J
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
    Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
    Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery.
    Ramracheya RD; McCulloch LJ; Clark A; Wiggins D; Johannessen H; Olsen MK; Cai X; Zhao CM; Chen D; Rorsman P
    Cell Rep; 2016 May; 15(5):944-950. PubMed ID: 27117413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
    Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1 signaling-regulated SNAP25 is involved in improved insulin secretion in diabetic GK rats after Roux-en-Y gastric bypass surgery.
    Kong X; Lin C; Yang C; Wang X; Li B; Yan D; Yang Y; Hu A; Chen Y; Xu X; Ma X
    Mol Biol Rep; 2024 Jan; 51(1):123. PubMed ID: 38227062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.
    Wang T; Shen Y; Qiao Z; Wang Y; Zhang P; Yu B
    Obes Surg; 2019 Apr; 29(4):1174-1184. PubMed ID: 30610678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.
    Amouyal C; Castel J; Guay C; Lacombe A; Denom J; Migrenne-Li S; Rouault C; Marquet F; Georgiadou E; Stylianides T; Luquet S; Le Stunff H; Scharfmann R; Clément K; Rutter GA; Taboureau O; Magnan C; Regazzi R; Andreelli F
    EBioMedicine; 2020 Aug; 58():102895. PubMed ID: 32739864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery?
    Qiu NC; Liu ME; Wang B; Song X; Jiang Y; Wang J; Gu ZQ; Shan CX; Qiu M
    J Gastrointest Surg; 2014 Nov; 18(11):1957-64. PubMed ID: 25183408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
    Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.